The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular resolution to enhance our understanding of cellular organization-function. HuBMAP will accelerate the development of the next generation of tools and techniques to generate 3D tissue maps using validated high-content, high-throughput imaging and omics assays, and establish an open data platform for integrating, visualizing data to build multi-dimensional maps. HuBMAP also intends to build partnerships with other funding agencies, programs, and the biomedical research community.
The HuBMAP recently issued two new Funding Opportunity Announcements (FOAs). These funding opportunities will focus on the following topics:
- Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3) RFA-RM-17-025
- Tissue Mapping Centers for the Human Biomolecular Atlas Program (U54) RFA-RM-17-027
FY18 initiatives for HuBMAP will include Technology Development, Tissue Mapping, and also the HuBMAP Integration, Visualization, and Engagement (HIVE) Collaboratory.
For additional information about HuBMAP activities, including pre-application technical assistance webinars and the HuBMAP mailing list, please visit: https://commonfund.nih.gov/hubmap.
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.
The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.